Lotus Mallbris, MD, phd; Brian J. Nickoloff, MD, phd Eli Lilly and Company, Indianapolis, Indiana Disclosure: Drs. Mallbris and Nickoloff are employees and stockholders of Eli Lilly and Company. This
aDavid Wirta, MD; bDavid M. Pariser, MD; cSteven G. Yoelin, MD; dSeiji Arase, MD; eAmy McMichael, MD; fEmily Weng, ScD; fCheri Mao, MSc; fGeorge Demos, MD*; fAmanda VanDenburgh, PhD aDavid
a,bMichael H. Gold, MD; aJulie A. Biron, BSc; aBrynne Thompson, RN, CCRP aTennessee Clinical Research Center, Nashville, Tennessee; bGold Skin Care Center, Nashville, Tennessee Disclosure: Dr. Gold is a consultant
Moetaz El-Domyati, MD; Manal Barakat, MD; Sherif Awad, MD; Walid Medhat, MD; Hasan El-Fakahany, MD; Hanna Farag, MD Department of Dermatology, Al-Minya University, Al-Minya, Egypt Disclosure: The authors report no
aEmily Osier, MD; bBarbara Gomez, PhD; aLawrence F. Eichenfield, MD aDivision of Pediatric and Adolescent Dermatology, University of California, San Diego, California; Rady Children’s Hospital, San Diego, California; bp-value communications,
